医薬品用ガラスバイアルの世界市場：市場規模（容量別・流通形態別・キャップサイズ別・地域別）、将来予測

医薬品用ガラスバイアルの市場規模と予測

医薬品用ガラスバイアル市場規模は、2024年に148億2,000万米ドルと評価され、2026年から2032年にかけてCAGR 6.94%で成長し、2032年には216億3,000万米ドルに達すると予測されています。

医薬品用ガラスバイアルは、液体医薬品、ワクチン、その他の医薬品の保存と保護に使用される小型の円筒形容器です。高品質で耐薬品性のあるガラスで作られたバイアルは、内容物の安定性と完全性を保証します。無菌状態を維持し、汚染を防ぐために、ゴム栓や金属キャップで密封するように設計されています。

医薬品用ガラス瓶は、医薬品、ワクチン、有機物質の安全で無菌の保管に使用されます。感染、光、湿度に対するバリアを提供し、内容物の安定性と有効性を保証します。ガラス瓶は、注射薬、経口液、診断試薬によく使用され、繊細な接続の完全性を維持する能力があります。

ドラッグデリバリーや包装技術の先進に伴い、医薬品用ガラスバイアルの用途は今後も拡大すると予想されます。ガラス瓶は、生物製剤やワクチンを含む注射薬の安全な保管と投与に不可欠であり続けるでしょう。ガラス製剤とバイアルの設計における革新は、耐久性と安全性を向上させ、汚染リスクを低減し、新しい薬物療法の開発をサポートします。

世界の医薬品用ガラスバイアル市場力学

世界の医薬品用ガラスバイアル市場を形成している主な市場力学は以下の通りです：

主な市場促進要因

生物製剤とワクチンの成長：生物製剤とワクチンの開発および商業化の増加は、医薬品用ガラスバイアルの需要を大きく促進しています。これらの製品は、その効力と安定性を維持するために、無菌で安全な包装が必要とされることが多いです。ガラスバイアルは、化学的相互作用や汚染を防ぐ不活性で保護的な環境を提供する能力から好まれています。

慢性疾患の増加：糖尿病、がん、心血管疾患などの慢性疾患の世界の増加は、注射薬や生物製剤の需要を促進しています。これらの治療では、安全性と有効性を確保するため、正確で無菌の包装ソリューションが必要とされることが多いです。ガラスバイアルは、デリケートな化合物の完全性を保つことができるため、これらの医薬品の包装に不可欠です。

ガラスバイアルの技術進歩：ガラスバイアルの製造技術の革新が、市場の主要な促進要因です。改ざん防止機能の開発、飛散防止ガラス処方、滅菌技術の向上などの進歩により、ガラスバイアルの安全性、耐久性、機能性が向上しています。

主な課題

汚染と破損のリスク：医薬品用ガラスバイアルは、汚染や破損の影響を受けやすく、その結果、封入されている医薬品の無菌性や安全性が損なわれる可能性があります。ガラス粒子が薬剤に混入し、副作用を引き起こす可能性があります。バイアルに欠陥がないことを確認し、製造時の品質管理を厳密に行うことが重要です。さらに、物理的な損傷を防ぐために、取り扱いと保管の方法を綿密に管理する必要があります。

製造コストと材料費：医薬品用ガラスバイアルの製造には、高品質のガラス材料と高度な製造技術が必要であり、コストがかかります。バイアルの寸法を正確かつ一定にするための特殊な設備や、厳格な滅菌手順が必要なため、コストはさらにかさみます。

規制遵守と規格：医薬用ガラス瓶は、安全性、有効性、および品質を確保するために、厳しい規制要件と業界標準を遵守する必要があります。FDAやEMAが定めるような国際的な規制への準拠には、進化する規格に対応するための継続的な更新と修正が必要です。そのため、メーカーは規制関連業務に投資し、広範な試験を実施し、コンプライアンスを証明する文書を整備する必要があります。

主要動向：

ガラスの製剤と技術進歩：世界の医薬品用ガラス瓶市場は、ガラス製造と技術においてかなりの進歩を遂げています。i型ホウケイ酸ガラスのような新しいタイプのGLAは、熱や化学反応に対する耐性が向上しており、これは繊細な医薬品や生物学的製剤の保存にとって極めて重要です。ガラスカバー技術の革新は化学的安定性を向上させ、薬剤の残留や相互作用のリスクを低減します。

生物製剤と個別化医療の成長：生物製剤と個別化医療の普及は、医薬品用ガラス瓶市場に影響を与える主要な動向です。ワクチン、モノクローナル抗体、遺伝子治療などの生物製剤は、有効性と安全性を維持するために無菌で高品質な包装ソリューションを必要とします。ガラスバイアルは、その不活性な性質と汚染から保護する能力により、これらの用途に好まれています。

持続可能性と環境への配慮：持続可能性は医薬品用ガラスバイアルの市場において重要な動向となっていますが、その背景には環境規制の高まりと企業責任への取り組みがあります。この業界では、リサイクルプログラムの実施や環境に優しい製造工程の採用など、ガラスプラスチックの製造と廃棄による環境への影響を軽減する方法を検討しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場区分
• 分析手法

第2章 エグゼクティブサマリー

• 主な分析結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 医薬品用ガラスバイアル市場：容量別

• 小容量バイアル（5ml未満）
• 大容量バイアル（5ml以上）

第5章 医薬品用ガラスバイアル市場：流通形態別

• 直販
• 販売業者
• オンラインマーケットプレース

第6章 医薬品用ガラスバイアル市場：キャップサイズ別

• 13mmバイアル
• 20mmバイアル
• 追加サイズ

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Schott AG（ドイツ）
• Nippon Glass Ltd.（日本）
• Bharat Parenterals Limited（インド）
• Gerresheimer AG（ドイツ）
• SGD Pharma（スイス）
• Becton, Dickinson and Company（BD）（米国）
• SCHOTT AG（ドイツ）
• AptarGroup, Inc.（米国）
• Ompi Ltd.（スイス）
• Neutral Glass Group（中国）

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Pharmaceuticals Glass Vials Market Size and Forecast

Pharmaceuticals Glass Vials Market Size was valued at USD 14.82 Billion in 2024 and is projected to reach USD 21.63 Billion by 2032, growing at a CAGR of 6.94% from 2026 to 2032.

Pharmaceutical glass vials are small, typically cylindrical containers used to store and protect liquid medications, vaccines, and other pharmaceutical products. Made from high-quality, chemically resistant glass, these vials ensure the stability and integrity of the contents. They are designed to be sealed with rubber stoppers and metal caps to maintain sterility and prevent contamination.

Pharmaceutical glass bottles are used for the safe and sterile storage of medicines, vaccines, and organic substances. They offer a barrier against infection, light, and humidity, thus guaranteeing the stability and effectiveness of the content. Glass bottles are often used for injectable medicines, oral liquids, and diagnostic reagents and the ability to maintain the integrity of sensitive connections.

The future use of glass vials for pharmaceuticals is expected to grow with advances in drug delivery and packaging technologies. They will continue to be essential for the safe storage and administration of injectable drugs including biologics and vaccines. Innovations in glass formulations and vial design will improve durability and safety, reduce contamination risks, and support the development of new drug therapies.

Global Pharmaceuticals Glass Vials Market Dynamics

The key market dynamics that are shaping the global Pharmaceuticals Glass Vials Market include:

Key Market Drivers:

Growth in Biologics and Vaccines: The increasing development and commercialization of biologics and vaccines is significantly driving the demand for glass vials for pharmaceutical products. These products often require sterile and secure packaging to maintain their potency and stability. Glass vials are preferred for their ability to provide an inert and protective environment preventing chemical interactions and contamination.

Rising Incidences of Chronic Diseases: The global rise in chronic diseases such as diabetes, cancer, and cardiovascular diseases is driving the demand for injectable drugs and biologics. These treatments often require precise and sterile packaging solutions to ensure their safety and efficacy. Glass vials are essential for packaging these medications as they can preserve the integrity of the delicate compounds.

Advancements in Glass Vial Technology: Innovations in glass vial manufacturing technology are a key driver of the market. Advancements such as the development of tamper-evident features, shatter-resistant glass formulations, and improved sterilization techniques are improving the safety, durability, and functionality of glass vials.

Key Challenges:

Risk of Contamination and Breakage: Pharmaceutical glass vials are susceptible to contamination and breakage which can compromise the sterility and safety of the medications they contain. Glass particles can potentially mix with the drug leading to adverse reactions. Ensuring that vials are free from defects and maintaining strict quality control during production is crucial. Additionally, handling and storage practices must be meticulously managed to prevent physical damage.

Cost of Production and Material: Producing pharmaceutical glass vials requires high-quality glass materials and advanced manufacturing techniques which can be costly. Expenses are further compounded by the need for specialized equipment to ensure accurate and consistent vial dimensions as well as rigorous sterilization procedures.

Regulatory Compliance and Standards: Pharmaceutical glass vials must adhere to stringent regulatory requirements and industry standards to ensure safety, efficacy, and quality. Compliance with international regulations such as those set by the FDA and EMA involves continuous updates and modifications to meet evolving standards. This requires manufacturers to invest in regulatory affairs, conduct extensive testing, and maintain documentation to demonstrate compliance.

Key Trends:

Advancements in Glass Formulation and Technology: The global glass bottle market in pharmaceutical products has considerable progress in glass manufacturing and technology. The new types of GLA such as type I borosilicate glass offer improved resistance to heat and chemical reactions which is of crucial importance for the storage of sensitive drugs and biologicals. Innovations in glass-covering technologies improve chemical stability and reduce the risk of leaving or interacting with drugs.

Growth in Biologics and Personalized Medicine: The increasing prevalence of biologics and personalized medicine is a key trend influencing the Pharmaceuticals Glass Vials Market . Biologics including vaccines, monoclonal antibodies, and gene therapies require sterile and high-quality packaging solutions to maintain efficacy and safety. Glass vials are preferred for these applications due to their inert nature and ability to protect against contamination.

Sustainability and Environmental Concerns: Sustainability has become an important trend in the market for glass bottles in pharmaceuticals which is due to rising environmental regulations and initiatives for corporate responsibility. The industry examines paths to reduce the environmental impact of glass plastic production and disposal, e.g. the implementation of recycling programs and the use of environmentally friendly manufacturing processes.

Global Pharmaceuticals Glass Vials Market Regional Analysis

Here is a more detailed regional analysis of the global Pharmaceuticals Glass Vials Market :

North America:

North America is the most dominant region in the pharmaceutical glass vials market. This dominance is primarily due to the presence of a well-established pharmaceutical industry and significant investments in research and development. The United States and Canada are home to numerous major pharmaceutical companies and contract manufacturing organizations that require high-quality glass vials for their pharmaceutical products including biologics and vaccines.

Additionally, North America's focus on innovation and growth in personalized medicine and biologics has intensified the need for specialized glass vials that can meet the unique requirements of these complex pharmaceutical formulations. The region's strong infrastructure including state-of-the-art manufacturing facilities and robust distribution networks supports its leading position in the global market.

Asia Pacific:

Asia Pacific is the fastest-growing region in the global pharmaceutical glass vials market. This growth is driven by rapid industrialization, increasing investments in healthcare infrastructure, and rising demand for pharmaceuticals and biologics. Countries such as China and India are expanding their pharmaceutical manufacturing capacity and increasing their production of injectable drugs, thereby significantly increasing the demand for glass vials.

Additionally, increasing local production of vaccines and biologics owing to global healthcare initiatives is further increasing the need for high-quality glass vials. In addition, the Asian-Pacific space benefits from cheap production and favorable regulatory environments and attracts local and international pharmaceutical companies. The accent put by the region on the improvement of health standards and the expansion of the pharmaceutical sector creates a robust market for glass bottles.

Pharmaceuticals Glass Vials Market: Segmentation Analysis

The Global pharmaceutical glass vials market is segmented based on Capacity, Mode of Distribution, Cap Size, and Geography.

Pharmaceuticals Glass Vials Market, By Capacity

• Small Volume Vials (less than 5ml)
• Big Volume Vials (5 ml or more)

Based on the Capacity, the Global Pharmaceuticals Glass Vials Market are bifurcated into Small Volume Vials, and Big Volume Vials. In the global Pharmaceuticals Glass Vials Market , small-volume vials are more dominant in the Pharmaceuticals Glass Vials Market . This dominance is driven by their widespread use in storing and administering high-value, potent medications, such as vaccines and biologics which often require precise, small doses. Their compact size makes them ideal for single-use or multi-dose applications ensuring accurate dosage and minimizing waste.

Pharmaceuticals Glass Vials Market, By Mode of Distribution

• Direct Sales,
• Distributors,
• Online Marketplaces

Based on the Mode of Distribution, the global Pharmaceuticals Glass Vials Market is bifurcated into Direct Sales, Distributors, and Online Marketplaces. In the global pharmaceutical glass vials market, direct sales are more dominant in the pharmaceutical glass vials market due to the need for specialized, high-quality packaging solutions that require close interaction between manufacturers and pharmaceutical companies. Direct sales enable manufacturers to provide tailored solutions offer technical support, and ensure compliance with stringent regulatory standards.

Pharmaceuticals Glass Vials Market, By Cap Size

13mm Vials,

20 mm Vials,

• Additional Sizes

Based on the Cap-Size Type, the Global Pharmaceuticals Glass Vials Market is bifurcated into 13mm Vials, 20 mm Vials, and Additional Sizes. In the global Pharmaceuticals Glass Vials Market , 20 mm vials are more dominant in the Pharmaceuticals Glass Vials Market due to their versatility and suitability for a wide range of drug applications including larger volume injectables and biologics. Their larger capacity accommodates more complex and high-volume formulations, which are increasingly common in the pharmaceutical industry.

Pharmaceuticals Glass Vials Market, By Geography

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Rest of the world

Based on Geography, the Global Pharmaceuticals Glass Vials Market is classified into North America, Europe, Asia Pacific, Middle East and Africa, and the Rest of the world. North America is the most dominant region in the Pharmaceuticals Glass Vials Market due to its advanced pharmaceutical industry, significant investments in research and development, and high demand for high-quality packaging solutions. The region's well-established infrastructure and stringent regulatory standards drive the need for superior glass vials to ensure drug safety and efficacy.

Key Players

The "Global Pharmaceuticals Glass Vials Market " study report will provide valuable insight with an emphasis on the global market. The major players in the market are Schott AG, Nippon Glass Ltd., Bharat Parenterals Limited, Gerresheimer AG, SGD Pharma, Becton, Dickinson and Company, SCHOTT AG, AptarGroup, Inc., Ompi Ltd., and Neutral Glass Group.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Pharmaceuticals Glass Vials Market Key Developments

• In June 2023, SDG SA announced its partnership with Corning Incorporated to establish a glass tubing facility in Telangana, India. The partnership combined SDG's expertise with Corning's glass coating technology to enhance fine-line productivity, thus initiating expansion in pharmaceutical manufacturing.
• In May 2023, Bormioli Pharma S.p.A renewed its partnership with Desall.com to develop innovation and ideas about pharmaceutical packaging by focusing on augmented reality solutions for drug delivery, and biometric recognition solutions to transform child-resistant closure systems.
• In March 2023, Schott AG launched the production of FIOLAX(R)amber pharma glass in India to meet its increasing demand in Asia. This production will improve the reliability, planning, availability, and cost-efficiency of pharmaceutical converters.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Pharmaceuticals Glass Vials Market, By Capacity

• Small Volume Vials (less than 5ml)
• Big Volume Vials (5 ml or more)

5. Pharmaceuticals Glass Vials Market, By Mode of Distribution

• Direct Sales
• Distributors
• Online Marketplaces

6. Pharmaceuticals Glass Vials Market, By Cap Size

• 13mm Vials
• 20 mm Vials
• Additional Sizes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Schott AG (Germany)
• Nippon Glass Ltd. (Japan)
• Bharat Parenterals Limited (India)
• Gerresheimer AG (Germany)
• SGD Pharma (Switzerland)
• Becton, Dickinson and Company (BD) (US)
• SCHOTT AG (Germany)
• AptarGroup, Inc. (US)
• Ompi Ltd. (Switzerland)
• Neutral Glass Group (China)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References